Concept paper: Strategies to identify and mitigate risks for first-in-human clinical trials with investigational medicinal products

As part of its advocacy program in Europe, ACRO submits regulatory comments to European officials. This comment letter, submitted by ACRO to EMA in 2016 about Concept paper: Strategies to identify and mitigate risks for first-in-human clinical trials with investigational medicinal products can be found below.

Concept paper: Strategies to identify and mitigate risks for first-in-human clinical trials with investigational medicinal products

Scroll to Top